References
- Fourrier A: Le syndrome maim existe-t-il encore? Lille Medical 10:404–413, 1965
- Lazarus A. Mann SC, Caroff SN: The Neuroleptic Ma-lignant Syndrome and Related Conditions. Washing-ton, D.C., American Psychiatric Press, 1989
- Kuhn WF, Lippman SB: Neuroleptic malignant syn-drome as a possible postoperative complication: a case report. Gen Hosp Psychiatry 9:179–181, 1987
- Montgomery JN, Ironside JW: Neuroleptic malignant syndrome in the intensive therapy unit. Anesthesia 45:311–313, 1990
- Levenson JL: Diagnosing and treating neuroleptic ma-lignant syndrome. Am J Psychiatry 143:675, 1986
- Nelson TE, Flewellen EH: The malignant hyperther-mia syndrome. N Engl J Med 309:416–418, 1983
- Hermesh H, Aizenberg D, Lapidot M, Munitz H: Risk of malignant hyperthermia among patients with neu-roleptic malignant syndrome and their families. Am J Psychiatry 145:1431–1434, 1988
- Johnson GC, Santos AB: More on ECT and malignant hyperthermia. Am J Psychiatry 140:266–267, 1983
- Grigg JR: Neuroleptic malignant syndrome and ma-lignant hyperthermia. Am J Psychiatry 145:1175, 1988
- Lazarus A, Rosenberg H: Malignant hyperthermia during ECT. Am J Psychiatry 148:541–542, 1991
- Addonizio G, Susman VL: ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. J. Clin Psychiatry 102–105, 1987
- American Psychiatric Association task force report. The practice of ECT: Recommendations for Treatment, Training, and Privileging. Washington, D.C., Amer-ican Psychiatric Press, 1990
- Burch EA, Downs J: Development of neuroleptic ma-lignant syndrome during simultaneous amoxapine treatment and alprazolam discontinuation. J Clin Psy-chopharmacology 7:55–56, 1987
- George AL, Wood CA: Succinylcholine-induced hy-perkalemia complicating the neuroleptic malignant syndrome. Ann Intern Med 106:172, 1987
- Greenblatt DJ, Gross PL, Harris J, Shader RI, Ciraulo DA: Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal. J Clin Psychiatry 39:673–675, 1978
- Hubbard JW, Ganes D, Midha KK: Prolonged phar-macologic activity of neuroleptic drugs. Arch Gen Psy-chiatry 44:99–100, 1987
- Spivak B, Weizman A, Wolovick L, Hermesh H, Ty-ano S. Munitz H: Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment. Acta Psychiatr Scand 81:168–169, 1990
- Lazarus A, Rosenberg H: Treatment of rehospitalized NMS patients. J Clin Psychiatry 51:84, 1990
- Sato T, Takeichi M: A case of neuroleptic malignant syndrome with a history of general anesthesia (En-glish translation). Kyushu Neuropsychiatry 33:41–45, 1987
- Franks RD, Aoueille B, Mahowald MC, Masson N: ECT use for a patient with malignant hyperthermia. Am J Psychiatry 139:1065–1066, 1982